Thermo Fisher Scientific (TMO) Tops Q1 EPS by 2c; Boosts FY15 EPS Midpoint Guidance

Thermo Fisher Scientific (NYSE: TMO) reported Q1 EPS of $1.63, $0.02 better than the analyst estimate of $1.61. Revenue for the quarter came in at $3.92 billion versus the consensus estimate of $4.01 billion.

Thermo Fisher Scientific sees FY2015 EPS of $7.25-$7.40, versus prior guidance of $7.22-$7.40 and the consensus of $7.32. Thermo Fisher Scientific sees FY2015 revenue of $16.67-16.83 billion, versus prior guidance of $16.80-17.00 billion and the consensus of $16.87 billion.

For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• UBS Reiterates Neutral Rating on Intuit (INTU), Says Investor Day Not 'Sentiment-Changing'
• Redburn upgrades Southwest, stays bullish on Delta and United